Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and DR-TB STAT will host a webinar on 1 August 2018 at 10 am New York / 4pm South Africa / 5pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB.
Dr. Nobert Ndejka from the National Department of Health in South Africa will be talking about the South African experience as the first country to roll out this unique and less toxic regimen. Dr. Maureen Kamene from the Ministry of Health in Kenya will be talking about practical considerations countries have in order to implement a bedaquiline-based, injectable-free regimen.
Perspectives from a survivor of drug-resistant TB and other members of civil society will also be included.
Closed captioning will be available.
Register for the webinar here to receive your log in information.